Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 15, Number 11—November 2009

Letter

Preexisting Immunity to Pandemic (H1N1) 2009

Zheng XingComments to Author  and Carol J. Cardona
Author affiliations: University of California, Davis, CA, USA (Z. Xing, C.J. Cardona); Medical School, Nanjing University, Nanjing, People’s Republic of China (Z. Xing)

Main Article

Table

Conserved MHC class I antigen-restricted epitopes present in HA and NP proteins of pandemic (H1N1) 2009 virus*

MHC antigen
Epitope
position
Sequence
Identified in selected
virus isolates
HA
HLA-A*0201 344–353 GLFGAIAGFI A/New Caledonia/20/1999 (H1N1)
A/Solomon Islands/3/2006 (H1N1)
A/Macau/229/2008 (H1N1)
A/Managua/254.01/2008(H1N1
NP
HLA-A1 44–52 CTELKLSDY A/Hong Kong/HKU4/2004 (H3N2)
HLA-A*0101 A/Canterbury/200/2004 (H3N2)
HLA-A3 265–273 ILRGSVAHK A/New Caledonia/20/1999 (H1N1)
A/New York/55/2004 (H3N2)
A/Managua/254.01/2008(H1N1)
A/Taiwan/2645/2006 (H1N1)
HLA-B27 380–393 ELRSRYWAIRTRSG A/New Caledonia/20/1999 (H1N1)
A/Taiwan/2645/2006 (H1N1)
A/Managua/254.01/2008(H1N1)
A/Florida/UR06-0383/2007(H1N1)
HLA-B27 174–184 RRSGAAGAAVK A/New Caledonia/20/1999 (H1N1)
A/New York/55/2004 (H3N2)
A/California/UR07-0067/2008 (H3N2)
A/Taiwan/2645/2006 (H1N1)
HLA-B*2705 357–370 KLSTRGVQIASNEN A/New Caledonia/20/1999 (H1N1)
A/New York/55/2004 (H3N2)
A/Hong Kong/HKU77/2005 (H3N2)
A/Managua/3153.01/2008 (H1N1)
HLA-B*2705 383–391 SRYWAIRTR A/New Caledonia/20/1999
A/Taiwan/2645/2006 (H1N1)
A/Managua/4537.03/2008 (H1N1)
A/Florida/UR07-0026/2008 (H1N1)
HLA-B*2702 381–388 LRSRYWAI A/New Caledonia/20/1999
A/Florida/UR06-0383/2007(H1N1)
HLA-B*4002 251–259 AEIEDLIFL A/Canterbury/200/2004 (H3N2)
A/Hong Kong/HKU71/2005 (H3N2)
HLA-B8 225–233 ILKGKFQTA A/New Caledonia/20/1999
A/California/UR07-0067/2008 (H3N2)
A/Taiwan/2645/2006 (H1N1)
HLA-B8 380–388 ELRSRYWAI A/New Caledonia/20/1999 (H1N1)
HLA-B*0801 A/Taiwan/2645/2006 (H1N1)
A/Managua/107.01/2008 (H1N1)
A/Florida/UR07-0026/2008 (H1N1)

*HA, hemagglutinin; NP, nucleoprotein; MHC, major histocompatibility complex; NA, neuraminidase. Epitope binding to and/or activation of specific lymphocytes prepared from human peripheral blood mononuclear cells (PBMC): MHC-tetramer staining; T-cell receptor binding; ELISPOT and intracellular cytokine staining (interferon γ), and/or 51Chromine release and killing have been demonstrated in published studies. Data on epitope characterization were collected from the Immune Epitope Database (IEDB; www.immuneepitope.org) (4).

Main Article

TOP